Business
InMed Pharmaceuticals to Report Second Quarter Fiscal 2020 Financial Results and Business Update on February 14, 2020
InMed Pharmaceuticals to Report Second Quarter Fiscal 2020 Financial Results and Business ...
About this update from Infield Minerals Corp
[{"type":"text","content":"\n\n\n\nInMed Pharmaceuticals to Report Second Quarter Fiscal 2020 Financial Results and Business Update on February 14, 2020\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen3{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; TEXT-ALIGN: LEFT; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnbcc{\nBORDER-TOP:0pt solid; BORDER-RIGHT:0pt solid; BORDER-COLLAPSE: COLLAPSE; BORDER-BOTTOM:0pt solid; BORDER-LEFT:0pt solid\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, Feb. 7, 2020\n\n\n\nVANCOUVER, Feb. 7, 2020 /CNW/ - InMed Pharmaceuticals Inc. (\"InMed\" or the \"Company\") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (CBN), will report financial results for the second quarter of fiscal year 2020 ending December 31, 2019 (\"2Q20\"), on Friday, February 14, 2020.\n\n \n \n\n \nConference Call & Webcast:\nFriday, February 14, 2020 at 8:30 AM Pacific Time, 11:30 AM Eastern Time\nLocal - Toronto\n(+1) 416 764 8688\nLocal - Vancouver\n(+1) 778 383 7413\nToll Free - North America\n(+1) 888 390 0546\nConference ID:\n93025046\nWebcast:  https://event.on24.com/wcc/r/2185404/4030244661FE992B9EE7D8F2024CDDDF\n \nReplays, Available through February 21, 2020: \nToronto:\n(+1) 416 764 8677\nNorth America (Toll Free):\n(+1) 888 390 0541\nPlayback Passcode:\n025046 #\n \nThe Company's full financial statements and related MD&A for the three months ended December 31, 2019 will be available at www.sedar.com on February 14, 2020.\nAbout InMed: InMed Pharmaceuticals is a clinical stage biopharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN), in diseases with high unmet medical need. The Company i...